4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-001075
Options or other derivatives
- Chief Financial Officer acquired 35,209 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Levy Adam D. Chief Financial Officer | 2025-04-01 | Grant or award · Stock Option (Right to Buy) | +35,209 | 35,209 | D | ||
Loading xslF345X05/form4.xml…